BRD4 plays an important role in the progression and prognosis of various tumors, such as oral squamous cell carcinoma, ovarian cancer, and lymphoma (Zhu et al., 2016; Hogg et al., 2017; Wang et al., 2019). Here, BRD4 is linked to lymphoma.